NCT03520660 2026-03-11
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Carcinoma, Hepatocellular × sofosbuvir-velpatasvir drug combination × Clear all